Search

By Industry Solutions (2)
By Phase (1)
By Molecule Type (1)
By Therapeutic Area (3)
Covance Events (9)
Geography (3)
Keywords (10)

Filters

Showing results 1313 - 1328 of 91813 for .

Showing results 1313 - 1328 of 91813 for .

In About 60 Seconds: Meet Dawn Chapman
In About 60 Seconds: Meet Dawn Chapman, PH.D., Senior Technical Manager, Sensory and Consumer
The Sound of Stronger Science Has Arrived
Our Combination Creates the Best End-to-End Partner for Pharmaceutical and Biotech Development
The Prescription for a Healthy, Infectious Disease Clinical Trial: Rich Science & Seamless Operations
This is a golden age for infectious disease clinical trials. Novel technologies give us a deeper understanding of the molecular mechanisms of disease states, and the body's responses to them. Increased access to a wider global patient population and new tools to visualize large data sets enable new insights into how diseases spread. And yet, the core problems in running a clinical trial remain: how to balance the use of novel technologies with maintaining strict operational control of the...
The Role of a CRO in Immuno-Oncology Studies - Role for the CRO
Watch this video to learn about the Role of a CRO in all phases of immuno-oncology drug development.
Webinar: Mobile Health - Managing the Process to Realize the Benefits
Patients are engaging with technology in ways that can produce longitudinal data measures and generate more powerful data analytics possibilites. However, regulatory expertise and planning in an evolving area of health care remains a critical need. The process of mobile device regulation can be managed to realize the benefits to clinical trials.
Pragmatic Solutions for Immuno-Oncology Clinical Trial Programs
Learn how to utilize historical data-driven methodology to identify investigators who are consistently excellent performers to ensure trial success.
Asembia Video
Get ready to experience forward thinking. Asembia April 20-May3
WEBINAR: Hot Topics in NASH
In this webinar, experts will discuss: 1) Genetic predisposition and other risk factors for disease progression 2) How to assess and monitor drug-induced liver injury (DILI) in patients 3) Strategic and statistical considerations for seamless adaptive design in NASH trials.
Xcellerate® Insights Demo Video - Chinese Subtitles
See how you can coordinate efforts in a secure, collaborative workspace and access your latest study summary reports with Xcellerate® Insights.
Xcellerate® Informatics Platform
See how the Xcellerate Infomatics platform enables a smarter trial.
Protecting Your Samples 24/7: LPS / Logistics
Innovative, automated LPS and logistics processes speed up the handling of your irreplaceable patient samples.
How does Covance deliver Solutions Made Real®?
Igniting projects, process and the entire industry.
Case Study: The Melamine Crisis
A contamination crisis arose when a compound used in household products around the world-melamine-had been used to adulterate infant formula. Covance delivered a precedent-setting turnaround time for method development and validation to our clients and provided them the insights they needed to feel confident that their brand.
The Role of a CRO in Immuno-Oncology Studies - Introduction
Watch this introduction video to learn about the Role of a CRO in Immuno-Oncology video series.
Non-Alcoholic Steatohepatitis (NASH): Preclinical and Clinical Development and Progress Toward Regulatory Approval Pathways
Learn more about the challenges of this "silent" liver disease along with therapeutic strategies to accelerate both clinical and regulatory efforts for this critical unmet medical need.
Xcellerate® Trial Design Demo Video-Chinese Subtitles
See how you can identify the most optimal sites and investigators by drawing on the world's largest proprietary clinical trial knowledge base with Xcellerate® Forecasting and Site Selection.